Philippe Pourquéry
Group CFO
Professional Overview
Philippe Pourquéry is a seasoned finance executive with extensive experience in the manufacturing and pharmaceutical industries. As the Group CFO of SGD Pharma, he leverages his strategic financial expertise to drive growth, operational efficiency, and long-term profitability for the organization.
Experience Summary
Current Role
Philippe has served as the Group CFO of SGD Pharma since May 2024. In this role, he is responsible for overseeing the company's financial strategy, reporting, and risk management. He works collaboratively with the executive team to ensure the alignment of financial goals with the organization's overall business objectives.
Career Progression
Prior to his current position, Philippe held the role of Group CFO at TERREAL, a leading manufacturer of clay-based building materials, from 2018 to 2024. During his tenure, he played a pivotal role in streamlining financial processes, improving cash flow management, and supporting the company's expansion into new markets.
Earlier in his career, Philippe served as the Group Deputy CFO at Albéa Group, a global leader in packaging solutions, where he contributed to the successful integration of acquisitions and the implementation of a centralized financial shared services model. He also held finance roles at Crown Holdings, Inc. and Abbott Laboratories, where he gained valuable experience in financial analysis, controlling, and reporting.
Academic Background
Philippe holds a Master of Business Administration (MBA) from Bowling Green State University and a degree from Audencia Business School, one of the top-ranked business schools in France.
Areas of Expertise
- Financial strategy and planning
- Corporate finance and treasury management
- Operational efficiency and cost optimization
- Mergers, acquisitions, and integration
- Financial reporting and compliance
- Risk management and internal controls
Professional Impact
During his tenure as Group CFO, Philippe has been instrumental in driving the financial transformation of SGD Pharma, streamlining financial processes, and enhancing the company's overall financial performance. He has also played a crucial role in supporting the organization's growth initiatives, including the successful integration of recent acquisitions.
Conclusion
With his extensive finance expertise, strategic mindset, and proven track record of success, Philippe Pourquéry is a valuable asset to SGD Pharma. As the Group CFO, he continues to contribute to the company's long-term growth and profitability, while upholding the highest standards of financial management and corporate governance.
